Indivior Pharmaceuticals, Inc. (INDV) reporting calendar
Indivior Pharmaceuticals, Inc. files periodic reports with the SEC as INDV on Nasdaq. Atlas tracks 7 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 13 Jul 2026 – 18 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 30 Apr 2026
- Reports on record
- 7
How this window is derived. Derived from this issuer's own filing history: 6 periods at a median 91-day cadence, filed a median 31 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open INDV market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 30 Apr 2026 | 30 days | 0001628280-26-028850 |
| 10-K | 31 Dec 2025 | 26 Feb 2026 | 57 days | 0001628280-26-012237 |
| 10-Q | 30 Sep 2025 | 30 Oct 2025 | 30 days | 0001628280-25-047530 |
| 10-Q | 30 Jun 2025 | 31 Jul 2025 | 31 days | 0001625297-25-000050 |
| 10-Q | 31 Mar 2025 | 1 May 2025 | 31 days | 0001625297-25-000030 |
| 10-K | 31 Dec 2024 | 3 Mar 2025 | 62 days | 0001625297-25-000016 |
| 20-F | 31 Dec 2023 | 6 Mar 2024 | 66 days | 0001625297-24-000017 |
Source: SEC EDGAR company submissions for CIK 0001625297. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.